Key | % Net Assets |
---|---|
BP PLC | 2.7% |
GlaxoSmithKline PLC | 2.7% |
Rio Tinto PLC | 2.1% |
Royal Dutch Shell PLC | 1.5% |
Other | 91% |
Name | % Net Assets |
---|---|
BP PLC | 2.7% |
GlaxoSmithKline PLC | 2.7% |
Rio Tinto PLC | 2.1% |
Royal Dutch Shell PLC | 1.5% |
AstraZeneca PLC | 1.4% |
HSBC Holdings PLC | 1.4% |
Standard Chartered PLC | 1.3% |
BG Group PLC | 1.1% |
Barclays PLC | 0.9% |
British American Tobacco PLC | 0.8% |
No asset data available.
Date | 09-Apr-2021 |
---|---|
Bid | 215.90p |
Offer | 215.90p |
Currency | GBP |
Change | 1.00p |
% | 0.47% |
YTD change | 215.90p |
YTD % | n/a |
Fund Inception | 26/08/1997 |
---|---|
Fund Manager | Sarah Arkle / Alex Lyle |
TER | - |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.20% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research